BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

676 related articles for article (PubMed ID: 10878285)

  • 1. Mycophenolate mofetil and its mechanisms of action.
    Allison AC; Eugui EM
    Immunopharmacology; 2000 May; 47(2-3):85-118. PubMed ID: 10878285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Purine metabolism and immunosuppressive effects of mycophenolate mofetil (MMF).
    Allison AC; Eugui EM
    Clin Transplant; 1996 Feb; 10(1 Pt 2):77-84. PubMed ID: 8680053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pharmacological profiles of mycophenolate mofetil (CellCept), a new immunosuppressive agent].
    Yashima Y; Ohgane T
    Nihon Yakurigaku Zasshi; 2001 Feb; 117(2):131-7. PubMed ID: 11233304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of action of mycophenolate mofetil in preventing acute and chronic allograft rejection.
    Allison AC; Eugui EM
    Transplantation; 2005 Oct; 80(2 Suppl):S181-90. PubMed ID: 16251851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of action of mycophenolate mofetil.
    Allison AC
    Lupus; 2005; 14 Suppl 1():s2-8. PubMed ID: 15803924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mycophenolate mofetil: An update.
    Villarroel MC; Hidalgo M; Jimeno A
    Drugs Today (Barc); 2009 Jul; 45(7):521-32. PubMed ID: 19834629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inosine monophosphate dehydrogenase variability in renal transplant patients on long-term mycophenolate mofetil therapy.
    Chiarelli LR; Molinaro M; Libetta C; Tinelli C; Cosmai L; Valentini G; Dal Canton A; Regazzi M
    Br J Clin Pharmacol; 2010 Jan; 69(1):38-50. PubMed ID: 20078611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism of action of mycophenolate mofetil.
    Ransom JT
    Ther Drug Monit; 1995 Dec; 17(6):681-4. PubMed ID: 8588241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mycophenolic acid inhibits activation of inducible nitric oxide synthase in rodent fibroblasts.
    Miljkovic Dj; Cvetkovic I; Stosic-Grujicic S; Trajkovic V
    Clin Exp Immunol; 2003 May; 132(2):239-46. PubMed ID: 12699411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mycophenolate mofetil--clinical and experimental experience.
    Pirsch JD; Sollinger HW
    Ther Drug Monit; 1996 Aug; 18(4):357-61. PubMed ID: 8857550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacology and toxicology of mycophenolate in organ transplant recipients: an update.
    Staatz CE; Tett SE
    Arch Toxicol; 2014 Jul; 88(7):1351-89. PubMed ID: 24792322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular mechanisms of new immunosuppressants.
    Halloran PF
    Clin Transplant; 1996 Feb; 10(1 Pt 2):118-23. PubMed ID: 8680047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The structure of inosine 5'-monophosphate dehydrogenase and the design of novel inhibitors.
    Sintchak MD; Nimmesgern E
    Immunopharmacology; 2000 May; 47(2-3):163-84. PubMed ID: 10878288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Review of the antiproliferative properties of mycophenolate mofetil in non-immune cells.
    Morath C; Zeier M
    Int J Clin Pharmacol Ther; 2003 Oct; 41(10):465-9. PubMed ID: 14703952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of mycophenolate mofetil on IMP dehydrogenase after the first dose and after long-term treatment in renal transplant recipients.
    Glander P; Hambach P; Braun KP; Fritsche L; Waiser J; Mai I; Neumayer HH; Budde K
    Int J Clin Pharmacol Ther; 2003 Oct; 41(10):470-6. PubMed ID: 14703953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of mycophenolate mofetil in transplant recipients.
    Mele TS; Halloran PF
    Immunopharmacology; 2000 May; 47(2-3):215-45. PubMed ID: 10878291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of Mycophenolate Mofetil (Cellcept) in renal transplantation.
    Vanrenterghem Y
    Nephron; 1997; 76(4):392-9. PubMed ID: 9274835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inosine monophosphate dehydrogenase activity in renal allograft recipients during mycophenolate treatment.
    Vethe NT; Mandla R; Line PD; Midtvedt K; Hartmann A; Bergan S
    Scand J Clin Lab Invest; 2006; 66(1):31-44. PubMed ID: 16464785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunosuppressive drugs: the first 50 years and a glance forward.
    Allison AC
    Immunopharmacology; 2000 May; 47(2-3):63-83. PubMed ID: 10878284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mycophenolate mofetil.
    Sievers TM; Rossi SJ; Ghobrial RM; Arriola E; Nishimura P; Kawano M; Holt CD
    Pharmacotherapy; 1997; 17(6):1178-97. PubMed ID: 9399601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.